James Kelly is a paralyzed American who is deeply involved in the therapeutic cloning debate, as he fervently wants to walk again. For years now, he has researched journal articles about stem cell research, corresponded with the scientists engaged in it, and become something of a lay expert in the entire field. He began a supporter of embryonic stem cell research. But he changed his mind. In his view, every dime that is poured into ESCR and cloning, is money unavailable for the areas where, based on his concentrated study, he sees his greatest hope for regaining mobility.
He knows of what he writes. This column, published in the Seoul Times makes some important points that the American MSM keep (willfully?) ignoring: Cloning is almost certainly not the best hope for cures for spinal cord injury in the soonest period of time. Well worth your time reading if you are interested in this issue.
Comments are visible to subscribers only. Log in or subscribe to join the conversation.
